Bipolar disorder, currently in remission Mental and Behavioural Disorders Bipolar disorder
Conditions
Interventions
1. Support will be provided as a medication internet-based psychoeducation module on relapse prevention and Biodose Connect™, which is an advanced medication and adherence management system using stat
Sponsors
Mednet Consult Ltd
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. International Statistical Classification of Diseases and Related Health Problems diagnosis: F31.7 bipolar disorder, currently in remission 2. Taking medication for bipolar disorder 3. Will be treated by Northern Health and Social Care Trust (UK) 4. Medication Adherence Rating Scale score of 6 or less 5. Clinical Global Impression score of 3 or less (mildly ill) 6. Home access to the internet via a laptop or desktop computer 7. Informed consent and registration forms 8. Co-medications and liquid medications can be administered via Biodose Connect™ 9. Age 18–64 years old
Exclusion criteria
Exclusion criteria: 1. Significant cognitive impairment 2. Taking medication that is identified by the Medicines and Healthcare Products Regulatory Agency (UK) as not suitable for blister/biodose packaging 3. Poor communication and/or reading skills
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient and health-care professional satisfaction scores will be captured with a satisfaction survey including rating scales and net promoter score at the end of the study (3 months after the start of study). | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in adherence scores from study baseline to end of the study (3 months after the start of study) will be measured with an adherence assessment tool, which includes the Medication Adherence Rating Scale score and the Clinical Global Impression score. | — |
Countries
United Kingdom
Contacts
Public ContactAyse Ibrahim
Outcome results
None listed